References
- Ceruti M, Crosasso P, Brusa P, et al. (2000). Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel. J Control Release 63:141–53
- Davis SS. (1997). Biomedical applications of nanotechnology-implications for drug targeting and gene therapy. Trend Biotechnol 15:217–24
- Dubey N, Varshney R, Shukla J, et al. (2012). Synthesis and evaluation of biodegradable PCL/PEG nanoparticles for neuroendocrine tumor targeted delivery of somatostatin analog. Drug Del 19:132–42
- El-Bagory IM, Honsy EA, Suwayeh AA, et al. (2007). Effects of sphere size, polymer to drug ratio and plasticizer concentration on the release of theophylline from ethyl cellulose microspheres. Saudi Pharm J 15:213–7
- Ellman GL. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–7
- Eniola AO, Hammer DA. (2003). Artificial polymeric cells for targeted drug delivery. J Control Release 87:15–22
- Gajbhiye V, Ganesh N, Barve G, Jain NK. (2013). Synthesis, characterization and targeting potential of zodovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers. E J Pharm Sci 48:668–79
- Hagan SA, Coombe AGA, Garnett MC, et al. (1996). S.S.Polylactide-poly(ethylene glycol) copolymers as drug delivery systems. 1. Characterization of water dispersible micelle-forming systems. Langmuir 12:2153–62
- Jin Y, Li J, Long-fu Rong, et al. (2005). Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice. Acta Pharmacol Sin 26:250–6
- Kim KY. (2007). Nanotechnology platforms and physiological challenges for cancer therapeutics. Nanomed 3:103–10
- Kostanski JW, DeLuca P. (2000). A novel in vitro release technique for peptide containing biodegradable microspheres. AAPS PharmSciTech 1:30–40
- Leo E, Pecquet S, Rojas J, et al. (1998). Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by w/o/w solvent evaporation method. J Microencaps 15:421–30
- Lynch TJ Jr, Kass F, Kalish LA, et al. (1993). Cisplatin, 5-Fluorouracil and etoposide for advanced non small cell lung cancer. Cancer 71:2953–7
- Moghimi SM, Hunter AC, Murray JC. (2001). Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318
- Nobs L, Buchegger F, Gurny R, Allemann E. (2003). Surface modification of poly (lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods. Int J Pharm 250:327–37
- Parikh RH, Parikh JR, Dubey RR, et al. (2003). Poly(D,L-lactide-co-glycolide) microspheres containing 5-fluorouracil: optimization of process parameters. AAPS PharmSciTech 4:1–8
- Richardson V, Jeyasingh K, Jewkes RF. (1977). Properties of 99mTc technetium- labeled liposomes in tumor bearing rat. Biochem Soc Trans 5:220–9
- Silverberg E, Boring CC, Squier TS. (1990). Cancer statistics. CA [A Cancer Journal for Clinicians] 40:9–26
- Suzuki KT, Karasawa A, Yamanaka K. (1989). Binding of copper to albumin and participation of cysteine in vivo and in vitro. Arch Biochem Biophys 273:572–7
- Takeda A, Goto R, Okada S. (1998). Mechanism of tumor transport of 99mTc-DL-Homocysteine, a possible tumor-imaging agent. Chem Pharm Bull 36:2570–5
- Thasneem YM, Sajeesh S, Sharma CP. (2011). Effect of thiol functionalization on hemo-compatibility of PLGA nanoparticles. J Biomed Mater Res A 99:607–17
- Tutus A, Nardali M, Gulmez I, et al. (1996). Evaluation of primary lung cancer with technetium-99m-l-Cysteine in comparison to thallium-201 uptake. Turkish J Nucl Med 5:33–9